To the central content area :::


Listed Companies

:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
6634 SINEW
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
Kai-Min Chu Kai-Min Chu Kai-Min Chu 02-27885365 C516, Building C, No.99, Lane 130, Sec.1, Academia Rd., Nangang Dist.Taipei City 115, Taiwan(R.O.C.) 2017/06/29
Key businesses
Biotechnology and Medical Care SINEW has six major products in two applications on hepatotoxicity-free acetaminophen (AAP) and fatty liver disease. SINEW, established in Taipei, Taiwan in 2014, is a new biopharmaceutical company with a focus on integrated new drug R&D. The breakthrough hepatotoxicity-free AAP product (that produces minimal toxic metabolite) and an antidote for AAP overdose can help solve the long-standing problem caused by chronic and/or incidentally AAP overdose-induced acute liver failure or even death over the past 30 years. Besides, we have developed a new safe product that may effectively treat fatty liver disease or steatohepatitis, for which there is no standard treatment yet. In the pipeline, we also have new chemical entities and new combos at the stage of preclinical research. At SINEW, our vision is to (1) become a world-class, innovation-based biopharmaceutical company, (2) comfort patient and (3) promote human health.
Market info
Latest trading info Historic trading info
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
profit and loss
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.